Log in to save to my catalogue

New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2420336221

New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

About this item

Full title

New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Cancer chemotherapy and pharmacology, 2020-07, Vol.86 (1), p.45-54

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Several clinical guidelines recommend genetic screening of
DPYD
, including coverage of the variants c.1905 + 1G>A(
DPYD
*2A), c.1679T>G(
DPYD
*13), c.2846A>T, and c.1129-5923C>G, before initiating treatment with fluoropyrimidines. However, this screening is often inadequate at predicting the occurrence of severe fluoro...

Alternative Titles

Full title

New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2420336221

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2420336221

Other Identifiers

ISSN

0344-5704

E-ISSN

1432-0843

DOI

10.1007/s00280-020-04093-1

How to access this item